2005
DOI: 10.1007/1-4020-8066-2_15
|View full text |Cite
|
Sign up to set email alerts
|

The Cost Effectiveness of Partially Effective HIV Vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
1
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 7 publications
2
1
0
Order By: Relevance
“…Our findings are broadly consistent with prior studies evaluating the cost-effectiveness of HIV vaccination in a late-stage epidemic setting [1215]. Although the cost-effectiveness of a partially effective HIV vaccine is more favorable in a high prevalence setting [15], our sensitivity analyses of variations in vaccine efficacy and duration of protection are consistent with prior modeling studies.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Our findings are broadly consistent with prior studies evaluating the cost-effectiveness of HIV vaccination in a late-stage epidemic setting [1215]. Although the cost-effectiveness of a partially effective HIV vaccine is more favorable in a high prevalence setting [15], our sensitivity analyses of variations in vaccine efficacy and duration of protection are consistent with prior modeling studies.…”
Section: Discussionsupporting
confidence: 89%
“…Although the cost-effectiveness of a partially effective HIV vaccine is more favorable in a high prevalence setting [15], our sensitivity analyses of variations in vaccine efficacy and duration of protection are consistent with prior modeling studies. Our finding that behavioral disinhibition in recipients of low-efficacy vaccines may attenuate the benefits associated with HIV vaccination is consistent with prior studies [36, 74].…”
Section: Discussionsupporting
confidence: 69%
“… 39 41 In fact, even before the realization of the RV144/Thai trial work, computer simulations of HIV transmission dynamics among South African adolescents underscored the important role of partially effective HIV vaccines irrespective of other public policy interventions. 42 Work by Owens et al 41 illustrated how varying degrees of vaccine efficacy for susceptibility, disease progression and infectivity still yielded substantial health benefits, even with only modestly efficacious vaccines. Based on the short-lived vaccine efficacy described by Rerks-Ngarm et al, 12 annual booster vaccinations were accounted for in the study model.…”
Section: Discussionmentioning
confidence: 99%